| Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in Rwanda (NCT07548021) | Medicines for Malaria Venture | 2026-09-01 |
| Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali. (NCT07758985) | Medicines for Malaria Venture | 2026-08-01 |
| Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants (NCT06558643) | Medicines for Malaria Venture | 2024-08-27 |
| Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru (NCT05361486) | Medicines for Malaria Venture | 2023-08-28 |
| Piperaquine Granule Formulation Relative Bioavailability and Food Effect Study in Healthy Volunteers. (NCT05930782) | Medicines for Malaria Venture | 2023-08-14 |
| Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum (NCT05979207) | Medicines for Malaria Venture | 2023-08-01 |
| First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV367 (NCT05507970) | Medicines for Malaria Venture | 2022-07-29 |
| MMV533 Plasmodium Falciparum Volunteer Infection Study (NCT05205941) | Medicines for Malaria Venture | 2022-03-30 |
| A Healthy Volunteer Safety Study of Pyronaridine Tetraphosphate Taken in Combination With Piperaquine Tetraphosphate (NCT05160363) | Medicines for Malaria Venture | 2022-02-14 |
| Atoguanil BA Study (NCT04866602) | Medicines for Malaria Venture | 2021-11-17 |
| Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Profile of Ruxolitinib With Artemether-lumefantrine (NCT04456634) | Medicines for Malaria Venture | 2020-09-10 |
| A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetic Profile of a Single Doses of MMV533. (NCT04323306) | Medicines for Malaria Venture | 2020-08-12 |
| Study in Blood Stage Malaria Infection After DVI of Cryopreserved P. Falciparum (NF54 Strain) Sporozoites (NCT04310085) | Medicines for Malaria Venture | 2020-02-19 |
| Determine the Tolerability and Safety of Atovaquone-proguanil (ATV-PG) Co-administered With Amodiaquine (AQ) (NCT04002687) | Medicines for Malaria Venture | 2019-04-04 |
| Safety, Tolerability and Chemoprotective Activity of P218 in PfSPZ Challenge Model (NCT03707041) | Medicines for Malaria Venture | 2018-11-16 |
| Malaria: Relative Bioavailability and Food Effect of DSM265 (NCT03637517) | Medicines for Malaria Venture | 2018-10-03 |
| Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP (NCT03542149) | Medicines for Malaria Venture | 2018-04-23 |
| Chemoprotective Activity of MMV390048 in PfSPZ Challenge Model (NCT03195387) | Medicines for Malaria Venture | 2018-01-01 |
| MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria (NCT02880241) | Medicines for Malaria Venture | 2017-10-20 |